|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/198 | (2006.01) |
| A61K 31/519 | (2006.01) | ||
| C07D 487/04 | (2006.01) |
| (11) | Number of the document | 3034075 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15191241.7 |
| Date of filing the European patent application | 2007-11-19 | |
| (97) | Date of publication of the European application | 2016-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-25 |
| (46) | Date of publication of the claims translation | 2018-11-26 |
| (30) | Number | Date | Country code |
| 860840 P | 2006-11-22 | US | |
| 861459 P | 2006-11-29 | US | |
| 957236 P | 2007-08-22 | US |
| (72) |
ZHUO, Jincong, US
METCALF, Brian, US
XU,Meizhong, US
HE, Chunhong, US
ZHANG, Colin, US
QIAN, Ding-quan, US
BURNS, David M., US
LI, Yunlong, US
YAO, Wenqing, US
|
| (73) |
Incyte Holdings Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Imidazotriazinai ir imidazopirimidinai kaip kinazės inhibitoriai |
| IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-11-03 | 19 | 347.00 EUR |
| 2026-11-19 |